BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23603603)

  • 1. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
    Aurangabadkar H; Ali Z
    Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
    Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
    Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
    Thambugala GM; Mohamed A; O' Neill GF; Fulham MJ
    Australas Radiol; 2006 Dec; 50(6):604-6. PubMed ID: 17107535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular myocardium metastasis in a patient with primary renal cell carcinoma detected by 18F-FDG PET/CT.
    Pinnamaneni N; Muthukrishnan A
    Clin Nucl Med; 2012 Jul; 37(7):e181-3. PubMed ID: 22691531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
    Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Malignant tumor with false negative 18F-FDG PET image].
    Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma presenting as isolated deltoid muscle metastasis 12 years after radical nephrectomy detected on 18F-FDG PET/CT.
    Bhoil A; Mittal BR; Bhattacharya A; Rane S; Nijhawan R; Gupta V
    Clin Nucl Med; 2013 Dec; 38(12):e474-6. PubMed ID: 23579976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic Renal Cell Cancer Treated With Antiangiogenic Therapy Monitoring by 18F-FDG PET/CT.
    García Garzon JR; Bassa P; Llinares E; Soler M; Moragas M; Riera E
    Clin Nucl Med; 2015 Nov; 40(11):910-1. PubMed ID: 26252325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
    Rangan B K K; Ora M; Suraj AS; Parashar A; Gambhir S
    Clin Nucl Med; 2019 Oct; 44(10):e574-e576. PubMed ID: 31348078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
    Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
    Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.
    Demirci E; Ocak M; Kabasakal L; Decristoforo C; Talat Z; Halaç M; Kanmaz B
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1461-2. PubMed ID: 24756358
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal Cell Carcinoma Arising From Renal Allograft Detected by 18F-FDG PET-CT.
    Guo Y; Wang T
    Clin Nucl Med; 2016 May; 41(5):412-3. PubMed ID: 26825198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
    Park JW; Jo MK; Lee HM
    BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic lung nodule diagnosed on 18F-FDG PET/CT-guided fine needle aspiration in a patient with renal cell carcinoma.
    Manohar K; Bhattacharya A; Vyas S; Dey P; Mandal AK; Abrar ML; Mittal BR
    Clin Nucl Med; 2013 Jan; 38(1):e38-9. PubMed ID: 23242063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare presentation of metastatic renal clear cell carcinoma to the tongue seen on FDG PET.
    Basely M; Bonnel S; Maszelin P; Verdalle P; Bussy E; de Jaureguiberry JP
    Clin Nucl Med; 2009 Sep; 34(9):566-9. PubMed ID: 19692815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
    Harrison MR; George DJ
    Clin Cancer Res; 2011 Sep; 17(18):5841-3. PubMed ID: 21926167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
    Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
    J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body PET/CT evaluation of tumor perfusion using generator-based 62Cu-ethylglyoxal bis(thiosemicarbazonato)copper(II): validation by direct comparison to 15O-water in metastatic renal cell carcinoma.
    Fletcher JW; Logan TF; Eitel JA; Mathias CJ; Ng Y; Lacy JL; Hutchins GD; Green MA
    J Nucl Med; 2015 Jan; 56(1):56-62. PubMed ID: 25525184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
    Fuccio C; Ceci F; Castellucci P; Spinapolice EG; Palumbo R; D'Ambrosio D; Bernardo A; Brunocilla E; Schiavina R; Maffione AM; Chondrogiannis S; Grassetto G; Colletti PM; Rubello D; Fanti S; Trifirò G
    Clin Nucl Med; 2014 Jun; 39(6):e320-4. PubMed ID: 24566409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
    Ye XH; Chen LH; Wu HB; Feng J; Zhou WL; Yang RM; Bu ZB; Ding Y; Guan J; Wang QS
    South Med J; 2010 Jul; 103(7):642-9. PubMed ID: 20531045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.